Aurinia Pharmaceuticals

AUPHNasdaq Canada Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.210 B

$16.61 -1.72%

Close of 21 Sept 2026

Revenue

$283.1M

#2150 by revenue

Earnings

$287.2M

#857 by earnings

Shares outstanding

133,051,168

Latest filing cover page

P/E ratio

7.7

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#98Prestige Consumer HealthcarePBH$2.22B
#99Palvella TherapeuticsPVLA$2.21B
#100Aurinia PharmaceuticalsAUPH$2.21B
#101Ocular TherapeutixOCUL$2.19B
#102BiohavenBHVN$2.15B

What if Aurinia Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $30.3T

$227,536.93

Per share 13,699× higher

Bitcoin $1.72T

$12,925.88

Per share 778× higher

Nvidia $5.48T

$41,186.09

Per share 2,480× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for Aurinia Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.